FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Continente #
EU - Europa 1.857
NA - Nord America 468
AS - Asia 406
AF - Africa 51
SA - Sud America 22
OC - Oceania 8
Totale 2.812
Nazione #
DE - Germania 1.349
US - Stati Uniti d'America 458
CN - Cina 148
SG - Singapore 145
IT - Italia 121
GB - Regno Unito 115
RU - Federazione Russa 67
SE - Svezia 59
MA - Marocco 50
IE - Irlanda 49
IN - India 32
ID - Indonesia 31
FI - Finlandia 20
HK - Hong Kong 19
NL - Olanda 16
FR - Francia 15
BR - Brasile 12
UA - Ucraina 10
DK - Danimarca 8
ES - Italia 8
JP - Giappone 8
TR - Turchia 8
AU - Australia 7
CA - Canada 7
KR - Corea 6
BE - Belgio 4
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
GR - Grecia 3
MX - Messico 3
AT - Austria 2
CL - Cile 2
LB - Libano 2
MT - Malta 2
MY - Malesia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IM - Isola di Man 1
KG - Kirghizistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.815
Città #
Frankfurt am Main 1.284
Singapore 100
Southend 99
Chandler 94
Milan 51
Dublin 49
Beijing 46
Princeton 36
Casablanca 31
Wilmington 30
Jakarta 24
Santa Clara 22
Seattle 21
Mountain View 14
Ashburn 13
Helsinki 13
Bengaluru 12
Berlin 12
Boardman 12
Des Moines 11
New York 11
Fairfield 10
Nuremberg 10
Hong Kong 9
Houston 9
Phoenix 9
Cambridge 7
Hyderabad 7
Toronto 7
Dearborn 6
Nanjing 6
Redmond 6
Edinburgh 5
Jacksonville 5
Jinan 5
Medford 5
Munich 5
Naples 5
Shanghai 5
Woodbridge 5
Agadir 4
Azzano San Paolo 4
São Paulo 4
Amsterdam 3
Ann Arbor 3
Athens 3
Bilthoven 3
Boston 3
Brussels 3
Central District 3
Eygelshoven 3
Hanover 3
Lappeenranta 3
Madrid 3
Manchester 3
Marrakesh 3
Mumbai 3
Nanchang 3
Pavia 3
Rho 3
Sakarya 3
Shenyang 3
Silver Spring 3
Yubileyny 3
Zhengzhou 3
Andover 2
Arezzo 2
Bandar Lampung 2
Barranquilla 2
Bolzano 2
Brandenburg 2
Bratislava 2
Catania 2
Chengdu 2
Chicago 2
Costa Mesa 2
Dresden 2
Eitensheim 2
Falkenstein 2
Formia 2
Glasgow 2
Grassobbio 2
Guangzhou 2
Guayaquil 2
Kuala Lumpur 2
Lucca 2
Menlo Park 2
Mexico City 2
Msida 2
Nürnberg 2
Orange 2
Paris 2
Philadelphia 2
Podenzana 2
Redwood City 2
Reggio Calabria 2
Rome 2
San Diego 2
Seoul 2
Sesto San Giovanni 2
Totale 2.259
Nome #
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 170
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 166
The PROCAINA (Prostate Cancer Indication Attitudes) Project (Part I): A survey among Italian radiation oncologists on post-operative radiotherapy in prostate cancer 159
A prospective phase II study on tandem autografting-nonmyeloablative allografting for newly diagnosed myeloma : final results of the Gruppo Italiano Trapianto Midollo Osseo 145
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: results of a multicenter study 144
Back to (new) normality-A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 127
Almost one year of COVID-19 pandemic : how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 126
Combination of novel systemic agents and radiotherapy for solid tumors - part I : An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 112
Combination of novel systemic agents and radiotherapy for solid tumors - Part II : an AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 110
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 109
A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small cell lung cancer 109
Development and implementation of proton therapy for hodgkin lymphoma: Challenges and perspectives 106
Current situation of proton therapy for hodgkin lymphoma: From expectations to evidence 101
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 98
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 92
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 88
The "PROCAINA (PROstate CAncer INdication Attitudes) Project" (Part II) - A survey among Italian radiation oncologists on radical radiotherapy in prostate cancer 87
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 78
Recent advancement on PD-L1 expression quantification : The radiologist perspective on CT-guided FNAC 76
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 70
A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer 66
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 64
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 64
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 62
Once-weekly hypofractionated whole-breast radiotherapy after breast-conserving surgery in older patients: A potential alternative treatment schedule to daily 3-week hypofractionation 62
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 62
Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review 55
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC 50
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 45
Treatment options in skeletal localizations of hairy cell leukemia: A systematic review on the role of radiation therapy 37
Primary duodenal follicular lymphoma : 6-years complete remission after combined radio-immunotherapy 35
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 32
Three-Dimensional Ultrasound-Based Image-Guided Hypofractionated Radiotherapy for Intermediate-Risk Prostate Cancer: Results of a Consecutive Case Series 28
What do radiation oncologists require for future advancements in lung SBRT? 18
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 9
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 1
Totale 2.963
Categoria #
all - tutte 8.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 0 3 17 8 7 0
2020/2021170 22 13 8 7 18 22 7 16 9 7 29 12
2021/2022188 4 3 12 9 15 6 6 5 12 9 24 83
2022/2023301 30 30 25 36 30 50 7 17 50 1 17 8
2023/20241.096 11 19 9 11 37 45 186 168 78 150 189 193
2024/2025871 196 214 186 114 53 50 44 14 0 0 0 0
Totale 2.963